On the other hand, METTL3 downregulation in endometrial cancer induces Akt prosurvival signaling by decreasing the expression of Akt inhibitor, PHLPP2 (PH domain and leucine-rich repeat protein phosphatase 2) (14). Here, AKT1 is linked to endometrial cancer.